unbalance of Ca 2+ in mitochondria or cytoplasm has been suggested to be associated with various physiological process including adenosine triphosphate (ATP) production, neuronal activation, cell death and apoptosis. The mitochondrial calcium uniporter (MCU) is a critical transmembrane protein that allows the passage of Ca 2+ from cytosol to mitochondria. 5 Under physiological conditions, MCU transports Ca 2+ to mitochondrial matrix, retaining the homeostasis of Ca
2+
. The balance of Ca 2+ in cell is essential for the cell's energy supply and cell survival. 6 However, under pathological conditions, excessive mitochondrial Ca 2+ uptake through the MCU is detrimental to mitochondrial function and can cause down-regulation of mitochondrial membrane potential (MMP), up-regulation of reactive oxygen species (ROS) and suppression of ATP production. 7 Cellular and mitochondrial accumulation of Ca 2+ leads to the activation of mitochondrial permeability transition pore. Subsequently, the pro-apoptotic proteins, such as cytochrome c, are released from mitochondrion to cytoplasm, resulting in apoptosis. 8, 9 Iron overload is a crucial factor involved in mitochondrial dysfunction in brain. Accumulation of iron concentration has been observed in many neurological diseases, such as TBI 10, 11 and intracerebral haemorrhage. 12 In neurons, iron exists in transferrin (Tf)-iron form, which is regulated by transferrin receptor protein (TfR). When neurons are injured, the Tf-iron-TfR complex is dissociated, and subsequently iron is released to cytoplasm. 13 Iron accumulation in cytoplasm may lead to cell death by destroying mitochondrial function, resulting in ROS generation and oxidative stress. 14 Recently, a growing number of researches have demonstrated that MCU was related to iron overload-triggered dysfunction of mitochondrion. It has been proposed that RU360, a MCU inhibitor, prevented iron overload-caused mitochondrial dysfunction in brain via attenuating production of ROS and depolarization of mitochondrion. 15 In addition, blockage of MCU could decrease the accumulation of iron in cytoplasm, alleviate apoptosis and brain injury following SAH by improving cell energy supply and suppressing ROS generation. 16 Overall, MCU is a major pathway for mitochondrial Ca 2+ and iron uptake. However, the accurate role of MCU-mediated Ca 2+ and iron accumulation in TBI is unclear. The present study is aimed to illustrate the accumulation of Ca 2+ and iron after TBI and to investigate the potential role of MCU as a therapeutic target in TBI.
| MATERIAL S AND ME THODS

| Animals
This study was carried out in accordance with the recommendations of guide for the Care and Use of Laboratory Animals by National
Institutes of Health (NIH). The protocol was approved by the Animal Care and Use Committee of Nanjing University. Male ICR mice (28-32 g) were obtained from Animal Center of Jinling hospital (Nanjing, China). Mice were housed on a 12 h light/dark cycle at 23 ± 1°C with free access to food and water.
| Primary culture of mouse cortical neurons
The culture of mouse cortical neurons was performed according to previous studies. 17, 18 In brief, mouse cortical neurons were isolated from the embryos of time-mated pregnant mice and subsequently cultured in poly-D-lysine-coated six-well dishes at a density of 
| Models of TBI
The in vivo (mouse) TBI model was performed with a modified version of the weight-drop model. 19 As described in our previous study, 20 mice
were anaesthetized with an intraperitoneal (ip) injection of chloral hydrate (1%, 5 ml/kg) and subsequently placed on the platform under the weight of the weight-drop device. With a 1.5 cm midline longitudinal incision of the scalp, the skull was exposed. Upon the impact area was situated at the left anterior frontal region (1.5 mm lateral to the midline on the mid-coronal plane), the weight was released from the height of 2.5 cm and dropped along a stainless steel string on the skull.
The mortality results from apnoea were decreased by early respiratory support. Then, the mice were returned to cages to recover for 24 hours with free access to a standard diet. The sham-injured mice underwent the same procedures, but did not undergo the weight drop.
The in vitro (neuron) model of TBI was conducted according to previous studies. 17, 18 Briefly, the six-well plates were manually scratched with a sterile plastic needle followed by a 9 × 9 square grid (the space between every line was 4 mm). Then, neurons were cultured at 37°C in 5% CO 2 incubator for another 24 hours without change of culture medium.
| Groups and drug administration
Both RR (catalogue number: R2751) and Sper (catalogue number: 85590) were purchased from Sigma-Aldrich. For in vivo studies, mice were divided into nine groups: sham, TBI, TBI + vehicle, TBI + RR
(1 mg/kg, 3 mg/kg, 5 mg/kg) and TBI + Sper (2 mg/kg, 5 mg/kg, 10 mg/kg). RR and Sper were dissolved in sterile saline solution and
given by ip administration 30 min after TBI. The doses of RR (1 mg/ kg, 3 mg/kg, 5 mg/kg) and Sper (2 mg/kg, 5 mg/kg, 10 mg/kg) used in our study were based on previous reports 21, 22 and our preliminary experiments.
For in vitro studies, neuronal cells were divided into five groups:
control, TBI, TBI + vehicle, TBI + RR and TBI + Sper. RR and Sper were firstly dissolved in dimethyl sulfoxide and then added to medium to achieve different final concentrations. The concentrations of RR (10 μmol/L) and Sper (10 μmol/L) used was based on previous studies 23 , 24 and our preliminary experiments.
| Neurological deficit and brain water content
The neurologic status of mice was estimated in 1, 3 and 7 days following TBI by the neurological severity score (NSS) and grip test.
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For NSS, the investigators evaluate the ability of mouse to perform 10 different tasks that indicate balance, motor function and alertness. One point is given for failing to perform each task, therefore 10 = maximum deficit and 0 = minimum deficit (Table 1) . For grip test, mice were placed onto a 45 cm long wire. The score criterion of grip test was shown in Table 2 . Both tests were performed in tree times and a total point was calculated for each mouse. Both the neurobehavioral tests were carried out by two investigators who were blinded to the experimental groups.
The brain water content was conducted depend on a previous study. 27 Briefly, mouse brain was taken out and placed onto a cooled brain matrix 1 day following TBI. The cerebellum and stem were taken away and the ipsilateral tissue was weighed to get the wet weight (ww). Then, the hemisphere was dried for 72 hours at 80°C
and weighed again to get the dry weight (dw). The brain water content equals (ww − dw)/ww × 100%.
| Measurement of lesion volume
The measurement of lesion volume of the brain was conducted according to a previous study.18 Briefly, mice were killed 7 days after TBI. The brains were collected, fixed for 12 hours and cryoprotected in 15% sucrose in PBS. The brain sections (500 mm intervals spanning the length of the brain) were stained with cresyl violet. The areas of the lesion, injured as well as non-injured cortex and hemisphere were estimated using an image analysis system. Area measurements from each section were obtained and summed, and corresponding volumes were calculated. Lesion volume was quantitatively analysed with Image-Pro Plus system and was showed as percent (the percentage volume of the non-injured hemisphere). The isolated mitochondria and cytoplasm were washed three times in Hanks' solution and then Fura-3-AM (5 μmol/L) was added in. The samples with Fura-3-AM were incubated in 37°C for 30 minutes. Then, the samples were washed with Hanks' solution three times to dislodge the excess Fura-3-AM and incubated at 37°C for 30 minutes again.
| Isolation of mitochondria
The fluorescence intensity was determined at an excitation of 506 nm and emission of 526 nm using a fluorescence microplate reader.
| Measurement of cellular ROS and ATP levels
The levels of ROS were measured by a fluorescence assay kit (Genmed Scientifics Inc, USA, catalogue number: GMS10016.3) and the levels of ATP were analysed by a ATP assay kit (Beyotime, China, catalogue number: S0026) based on the instruction from the manufacturer.
| Western blot analysis
Western blot analysis was performed according to previous studies. 28 Proteins were separated by 8%-12% sodium dode- Technology, USA, catalogue number: AP0060). Then, the membranes were incubated with corresponding secondary antibodies at room temperature for 2 hours.
| Iron staining
For iron staining, the 7 μm frozen sections were washed with phos- 
| Transmission electron microscope (TEM) observation
We used TEM to identify mitochondria as previously described.
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Briefly, at 1 day after TBI, the mice were killed and perfused with 2.5% buffered glutaraldehyde. The specimens were collected and fixed in glutaraldehyde with a 1% (w/v) solution of osmium tetroxide. The fixed specimens were then embedded, sectioned, double stained with lead citrate and uranyl acetate, observed under a TEM JEM-1011 (JEOL, Japan).
| Nissl staining
For Nissl staining, the sections (4 μm) were hydrated with 1% toluidine blue for 20 min at 50°C. After washing with double distilled water, the sections were dehydrated and mounted with permount. For quantification, six random high-power fields (400×) surrounding contusion were chosen and the mean number of surviving neurons in the six fields was considered as the data of each section. A total of four sections from each animal were used for quantification. The final average number of the four sections was regarded as the data for each sample.
Data were presented as the number of neurons per high-power field.
All the processes were performed by two independent pathologists who had no prior knowledge of the group assignments.
| TUNEL staining
The TUNEL staining was conducted using an In Situ Cell Death Detection Kit (Roche Inc, USA, catalogue number: 11684817910) based on our previous studies. 18 In brief, the sections were incubated with labelling solution containing TUNEL at 37°C for 1 hour.
The brain injury was expressed by the apoptotic index, known as the average percentage of apoptotic cells in each section counted in six cortical microscopic fields (400×). The apoptotic cells were measured by two independent observers blinded to the groups. 
| Cell viability analysis
| Measurement of neuron ROS levels
The levels of ROS in neuron were measured with a ROS assay kit were collected using a single rapid scan. In addition, we analysed the levels of ROS by a fluorescence microplate reader (BioTek USA).
Cells were stained with DCFH-DA, rinsed with PBS and centrifuged for 5 minutes at 1000 g, the supernatant was removed and the remaining cells were resolved with 1% Triton X-100. Fluorescence was analysed at an excitation wavelength of 488 nm and at an emission wavelength of 525 nm.
| Statistical analysis
All statistical analyses were performed with SPSS 19.0 (SPSS Inc, Chicago, IL). Each experiment was repeated at least three times.
Continuous variables were presented as mean ± SEM. For the behavioural tests, Kruskal-Wallis and Mann-Whitney U analysis were used to compare the data between multiple experimental groups because they were categorical variables. For other assays, one-way analysis of variance (ANOVA) followed by Tukey's test was used. A value of P < 0.05 was considered statistically significant.
| RE SULTS
| General observations and the mortality rate of mice
A total of 398 mice were used in this study, among them 51 mice died during the operation. 
| RR and Sper provided neuroprotection after TBI
To determine whether regulation of MCU could provide neuroprotective effects following TBI, we set nine groups as follows:
sham, TBI, TBI + vehicle, TBI + RR (1 mg/kg, 3 mg/kg, 5 mg/kg) and TBI + Sper (2 mg/kg, 5 mg/kg, 10 mg/kg). Firstly, we used NSS and grip test to study the motor performance of mice after TBI. Our results indicated that the RR-treated mice showed better motor performance than that of the vehicle-treated mice at 1 day ( Figure 1A , B). In addition, at 3 days, a significant difference was still detectable.
However, there was no significant difference between these two groups at 7 days (P > 0.05). Surprisingly, the mice treated with Sper also presented better motor performance than the TBI + vehicle group ( Figure 1A,B) . RR (3 mg/kg) or Sper (5 mg/kg) treatment after TBI, n = 6 each group. Data are presented as mean ± SEM; **P < 0.01, ***P < 0.001 vs sham group; # P < 0.05, ## P < 0.01, ### P < 0.001 vs TBI + vehicle group. Scale bar: 50 μm 
| RR and Sper reversed TBI-induced cellular iron accumulation
Iron homeostasis is closely mediated by Tf-TfR internalization for iron uptake, Ft for iron storage and Fpn-1 for iron export in cells.
In our study, cellular iron was accumulated after TBI as proven by iron staining (Figure 2A) . Moreover, the expression of TfR and Ft was obviously increased and the expression of Fpn-1 was decreased ( Figure 2B ), suggesting that iron was transported to cells. However, treatment with RR or Sper significantly attenuated the accumulation of iron (Figure 2A) , down-regulated the protein levels of TfR and Ft, and up-regulated the protein levels of Fpn-1 compared to the TBI + vehicle group ( Figure 2B ), demonstrating that TBI-induced accumulation of iron was reversed by inhibition of MCU.
| RR and Sper prevented TBI-triggered disruption of cellular iron homeostasis
The proteins were down-regulated after TBI, however RR or Sper treatment reversed these effects. Data are presented as mean ± SEM, n = 6 per group; **P < 0.01, ***P < 0.001 vs sham group; # P < 0.05, ### P < 0.001 vs TBI + vehicle group. β-actin was used as a loading control
| TBI elevated ROS Levels and limited mitochondrial ATP generation
Calcium and iron overload may lead to excessive generation of ROS and insufficient supply of ATP. Therefore, to investigate whether ROS production and ATP reduction after TBI was associated with mitochondrial Ca 2+ and iron overload, we measured ROS and ATP levels. In the sham group, low levels of ROS were observed.
However, a significant increase in ROS generation was observed in the TBI and TBI + vehicle groups. After treatment with RR or
Sper, the levels of ROS were evidently less than the TBI + vehicle group ( Figure 3A ). In addition, compared to the sham group, the ATP levels in TBI and TBI + vehicle groups decreased dramatically.
However, RR or Sper treatment fundamentally increased the ATP supply ( Figure 3B ).
| RR and Sper ameliorated TBI-induced deformation of mitochondria
Mitochondrial Ca 2+ and iron accumulation, as well as increased ROS generation and insufficient ATP supply, may lead to mitochondria swelling. In order to evaluate the mitochondrial injury following TBI, we used TEM to observe the mitochondrial morphology. In the sham group, TEM showed intact mitochondria, with double membranes visible, cristae structurally intact and round in shape. Conversely, the mitochondrial morphology of TBI and TBI + vehicle groups were swelling shape, near disappearance of the cristae and disruption of the membranes, which lost typical mitochondrial structure ( Figure 4A ). However, RR or Sper treatment protected the mitochondrion from deformation ( Figure 4A ).
| The expression of protein related to mitochondrial morphology
To explain the mechanisms of mitochondrial morphology changes after TBI, we examined some proteins that are associated with mitochondria fission and fusion. Drp1 and Fis1 are key proteins regulating mitochondrial fission, and MIEF1 is involved in mitochondria fusion.
Therefore, we examined the expression of these proteins after TBI.
Compared to sham group, the expression of Drp1, Fis1 and MIEF1 increased significantly in TBI and TBI + vehicle groups ( Figure 4B ).
However, when TBI mice was treated with RR or Sper, the expression of these proteins was apparently decreased ( Figure 4B ). These results indicated that blockage of MCU reversed TBI-induced change of Drp1, Fis1 and MIEF1, thus protecting the mitochondria from deformation.
| RR and Sper reversed TBI-induced neuron death
The damage of mitochondrion following TBI could cause the release of pro-apoptotic proteins from mitochondrion to cytosol, leading to apoptosis. Moreover, TBI-induced apoptosis in the early response may result in neuron death. To verify the occurrence of neuron death, we applied Nissl staining to clarify the morphology change and number of cortex neurons after TBI. In the sham group, the neurons were intact and clear, without oedema around the cells.
While in the TBI and TBI + vehicle groups, the damaged neuron cells was increased, exhibiting extensive degenerative changes including swollen cell bodies, shrunken cytoplasma, sparse cell arrangements and oval or triangular nucleus. On the contrary, the severity of neuron damage in the TBI + RR or TBI + Sper groups was significantly alleviated ( Figure 5A ).
| RR and Sper blocked TBI-induced DNA damage and apoptosis
To examine TBI-induced DNA damage of neural cells, we used 
| RR protected primary cultured neurons from TBI
The neuroprotective effects of RR and Sper were also confirmed in primary cultured neurons. LDH release assay and TB staining were Figure 7B showed that compared to the control neurons, the levels of ROS in the damaged neurons were significantly increased. When neurons were treated with RR, the levels of ROS were obviously decreased. Consistent with the results of LDH release assay and TB staining, treatment of Sper did not change the levels of ROS compared with the TBI + vehicle group ( Figure 7B) .
Besides, the marker of apoptosis such as cleaved caspase-3, the markers of mitochondrial damage such as Drp1, MIEF1 and Fis1 and the markers of iron accumulation such as IRP1/2 were analysed. We found that compared to the control neurons, cleaved caspase-3, Drp1, MIEF1 and Fis1 were increased while IRP1/2 was decreased in Iron is necessary for cell growth and differentiation in multiple organs particularly in the brain because of its role as a constituent of molecules generating mitochondrial energy. 33 Although iron plays an important role in CNS, abnormally high levels of iron in brain may lead to cognitive and motor deficits. 34, 35 The mechanisms of iron overload-induced brain disorders are related to the dysfunctions of mitochondrion. 36 Iron enters the mitochondrion, reacts with lipids to generate alkoxy and peroxy radicals and with hydrogen peroxide to form hydroxyl radicals, causing the generation of ROS. 37 ROS then leads to the depolarization of MMP and subsequently damages mitochondrion. 38 Therefore, iron is a potential target for treatment of brain trauma. However, the transmembrane pathway of iron entery into mitochondrion is still unclear. There are studies showing that MCU could facilitate mitochondrial iron uptake. 15, 39 Under normal conditions, Ca 2+ enters the mitochondrion through MCU. However, other anions such as Mn 2+ and Sr 2+ could also enter the mitochondrion via MCU because of the equal positive charges. 40 As iron (Fe   2+   ) and Ca 2+ also have equal positive charges, it may be the reason that iron could use MCU as a pathway to enter into mitochondrion.
| D ISCUSS I ON
Consistently, our study showed that the inhibition of MCU obviously attenuated iron overload. As both Ca 2+ and iron could translocate into mitochondrion through MCU, suppression of Ca 2+ and iron F I G U R E 6 Ruthenium red (RR) or Sper treatment inhibited traumatic brain injury (TBI)-induced up-regulation of apoptosis-related proteins. (A, B) Mice were subjected to TBI and treated with RR (3 mg/kg), Sper (5 mg/kg) or vehicle 30 min after TBI. Ipsilateral brain tissues were collected 1 day after TBI and the protein levels of cytochrome c and cleaved caspase-3 were measured by Western blot. RR or Sper treatment significantly decreased apoptosis induced by TBI. Data are presented as mean ± SEM, n = 6 per group; **P < 0.01, ***P < 0.001 vs sham group; # P < 0.05, ## P < 0.01, ### P < 0.001 vs TBI + vehicle group. COX IV was used as a loading control for mitochondria extracts. β-actin was used as a loading control for cytoplasmic and whole-cell extracts accumulation by blockage of MCU may stabilize mitochondrion. As a result, ROS generation reduced, energy supply increased and neuronal cell death and apoptosis decreased.
Although Sper has been proposed as an antioxidant in physiological concentrations, 41 the protective effects of Sper observed in our TBI models differ from its role in other models of brain injury. 22, 42 In these studies, Sper was shown to promote neuronal Primary cortical neurons were subjected to scratch injury and then treated with RR (10 μM), Sper (10 μM) or saline for 1 day. The LDH release assay and TB staining were used to evaluate cell viability. The percentage of damaged cells significantly increased after TBI compared to the control group. RR treatment significantly decreased damaged cells after TBI, however, Sper treatment had no significant impact compared to the TBI + vehicle group. (B) Cells were subjected to scratch injury and subsequently treated with RR (10 μM), Sper (10 μM) or saline for 1 day. Then cells were incubated with DCFH-DA and subjected to fluorescent microscopy analysis. The intracellular ROS was significantly increased after TBI compared to the sham group, and administration of RR instead of Sper significantly repressed ROS production as compared to the TBI + vehicle group. (C) RR (10 μM) treatment significantly decreased the expression of cleaved caspase-3 after TBI, however, Sper treatment had no obvious effect. Data are presented as mean ± SEM, n = 6 per group; **P < 0.01, ***P < 0.001 vs control group; # P < 0.05, ## P < 0.01, ### P < 0.001 vs TBI + vehicle group; @ P > 0.05 vs TBI + vehicle group. β-actin was used as a loading control. Scale bar: 50 μm protect neurons from ischaemic injury by enhancing autophagic flux. 46, 47 Moreover, induction of autophagic flux in immune cells by spermine may also reduce brain injury by suppressing inflammation. 48, 49 Given that spermine activates rather than suppresses MCU activity, these mechanisms may explain the neuroprotective effects of spermine in the in vivo TBI model that is characterized by inflammation and the neuroprotective failure in the in vitro TBI model which is not. Secondly, RR is a general inhibitor of sodium and calcium channels, 50 it also blocks ryanodine receptors located in the sarcoplasmic/endoplasmic reticulum that may promote cell death. 51, 52 Thus, RR is not a selective MCU inhibitor and may have protected neurons by blocking excessive plasma membrane calcium and sodium channel activities as well as the ryanodine receptor in addition to the MCU. Thirdly, RR has a strong positive charge and does not cross the blood-brain barrier. 54 Therefore, RR may be unlikely to reach brain concentrations necessary for neuroprotection following systemic administration. This suggests that RR may act on peripheral sites to reduce brain injury such as vascular endothelial cells, 55 so reduced mitochondrial calcium content in mice subjected to TBI by RR may be secondary to decreased brain injury. However, these speculations are obtained from previous literatures and whether theses speculations are correct is unclear, we will clarify them in our future studies.
In conclusion, our study indicated that inhibition of MCU or prevention of Ca 2+ and iron accumulation could exert neuroprotection against TBI by combating mitochondria damage, oxidative stress, neuronal cell death and apoptosis. These results make MCU a potential therapeutic target in TBI treatment in the future.
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F I G U R E 8 Traumatic brain injury (TBI)-induced damage of mitochondria and disruption of iron homeostasis were improved by ruthenium red (RR) in primary cultured neurons. (A, B) RR treatment significantly decreased the expression of Drp1, MIEF1 and Fis1 (A) and increased the expression of IRP1/2 (B) after TBI, however, Sper treatment had no obvious effect on these proteins. Data are presented as mean ± SEM, n = 6 per group; **P < 0.01, ***P < 0.001 vs control group; ## P < 0.01, ### P < 0.001 vs TBI + vehicle group; @ P > 0.05 vs TBI + vehicle group. β-actin was used as a loading control
